CUV 1.78% $14.84 clinuvel pharmaceuticals limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-31

  1. 1,243 Posts.
    lightbulb Created with Sketch. 108
    I expect sub $20 by end of month, but will not be buying back in unless management lift their game.
    Half year report due end month should be interesting, expect a big drop that day too.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.